Go Back

Company or ticker...

CRISPR Therapeutics

CRISPR Therapeutics develops gene-editing treatments for blood disorders, cancer, and rare diseases.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

CRSP

5.3B

406.8

n/a

3.89%

Key Facts

M. Cap

PS

PE

YTD

5.3B

406.8

n/a

3.89%

10MA

20MA

50MA

200MA

$CRSP

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

Join Now

Join Now